Effect of media on growth rate and susceptibility testing of Cryptococcus neoformans

被引:3
作者
StGermain, G
Dion, C
机构
[1] Lab. de S. Publique du Québec, Sainte-Anne-de-Bellevue, Que.
[2] Lab. de S. Publique du Québec, Sainte-Anne-Bellevue, Que. H9X 3R5
关键词
Cryptococcus neoformans; antifungal agents; susceptibility testing;
D O I
10.1111/j.1439-0507.1996.tb00125.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The effect of four media or media combinations on the growth and the in vitro susceptibility to amphotericin B, 5-fluorocytosine, fluconazole and itraconazole of 51 isolates of Cr. neoformans was studied. The drug concentration producing a 50% decrease in OD405 (IC50) was determined in microtiter format. The following MOPS buffered media or media combinations (antifungal drug diluent/inoculum diluent) were used: RPMI 1640 (RPMI)/RPMI, Yeast nitrogen base (YNB)/YNB, RPMI/YNB and RPMI/High resolution broth. Amphotericin B was further tested in M3 broth in the microdilution format and on RPMI agar with the E-test. Growth rates, (OD405) were higher in YNB, RPMI/YNB, RPMI/HR and M3 as compared to RPMI alone. After 48 h of incubation, IC50 values obtained with RPMI alone and with RPMI/YNB correlated within two dilutions for 98, 95, 95 and 100% of test strains with amphotericin B, 5-fluorocytosine, fluconazole and itraconazole respectively. The E-test provided the widest range of IC values with amphotericin B. Growth of Cr. neoformans can be enhanced in susceptibility tests using microtiter plates with drugs diluted in RPMI by preparing the inoculum in YB. However, when using spectrophotometric endpoint determinations, sufficient growth is obtainable with most isolates for test interpretation at 48 h in RPMI alone.
引用
收藏
页码:201 / 206
页数:6
相关论文
共 11 条
[1]  
[Anonymous], 1992, M27P NCCLS
[2]   COMPARATIVE-STUDY OF BROTH MACRODILUTION AND MICRODILUTION TECHNIQUES FOR IN-VITRO ANTIFUNGAL SUSCEPTIBILITY TESTING OF YEASTS BY USING THE NATIONAL-COMMITTEE-FOR-CLINICAL-LABORATORY-STANDARDS PROPOSED STANDARD [J].
BARCHIESI, F ;
COLOMBO, AL ;
MCGOUGH, DA ;
RINALDI, MG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (10) :2494-2500
[3]  
DELPOETA M, 1994, MYCOSES, V37, P411, DOI 10.1111/j.1439-0507.1994.tb00391.x
[4]   SUSCEPTIBILITY TESTING OF CRYPTOCOCCUS-NEOFORMANS - A MICRODILUTION TECHNIQUE [J].
GHANNOUM, MA ;
IBRAHIM, AS ;
FU, Y ;
SHAFIQ, MC ;
EDWARDS, JE ;
CRIDDLE, RS .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (11) :2881-2886
[5]   RESISTANCE TO AMPHOTERICIN-B ASSOCIATED WITH DEFECTIVE STEROL DELTA(8-]7) ISOMERASE IN A CRYPTOCOCCUS-NEOFORMANS STRAIN FROM AN AIDS PATIENT [J].
KELLY, SL ;
LAMB, DC ;
TAYLOR, M ;
CORRAN, AJ ;
BALDWIN, BC ;
POWDERLY, WG .
FEMS MICROBIOLOGY LETTERS, 1994, 122 (1-2) :39-42
[6]   OXYGEN AS LIMITING NUTRIENT FOR GROWTH OF CRYPTOCOCCUS-NEOFORMANS [J].
ODDS, FC ;
DEBACKER, T ;
DAMS, G ;
VRANCKX, L ;
WOESTENBORGHS, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (04) :995-997
[7]   SELECTION OF CANDIDATE QUALITY-CONTROL ISOLATES AND TENTATIVE QUALITY-CONTROL RANGES FOR IN-VITRO SUSCEPTIBILITY TESTING OF YEAST ISOLATES BY NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS PROPOSED STANDARD METHODS [J].
PFALLER, MA ;
BALE, M ;
BUSCHELMAN, B ;
LANCASTER, M ;
ESPINELINGROFF, A ;
REX, JH ;
RINALDI, MG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (07) :1650-1653
[8]   COMPARISON OF VISUAL AND SPECTROPHOTOMETRIC METHODS OF MIC END-POINT DETERMINATIONS BY USING BROTH MICRODILUTION METHODS TO TEST 5 ANTIFUNGAL AGENTS, INCLUDING THE NEW TRIAZOLE-D0870 [J].
PFALLER, MA ;
MESSER, SA ;
COFFMANN, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (05) :1094-1097
[9]  
POWDERLY WG, 1993, INFECT DIS CLIN PRAC, V1, P314
[10]   DETECTION OF AMPHOTERICIN B-RESISTANT CANDIDA ISOLATES IN A BROTH-BASED SYSTEM [J].
REX, JH ;
COOPER, CR ;
MERZ, WG ;
GALGIANI, JN ;
ANAISSIE, EJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (04) :906-909